ÇAKMAK, H. M. Et Al. 2022. Sorafenib as a maintenance therapy in an adolescent with relapsed-metastatic osteosarcoma. Eskisehir Medical Journal, Eskisehir City Hospital , vol.3 .

ÇAKMAK, H. M., BİLDİRİCİ, Y., Çorapçıoğlu, F., KAYI CANGIR, A., ÖZGER, N. H., & Adıgüzel, Y., (2022). Sorafenib as a maintenance therapy in an adolescent with relapsed-metastatic osteosarcoma. Eskisehir Medical Journal, Eskisehir City Hospital , vol.3.

ÇAKMAK, HATİCE Et Al. "Sorafenib as a maintenance therapy in an adolescent with relapsed-metastatic osteosarcoma," Eskisehir Medical Journal, Eskisehir City Hospital , vol.3, 2022

ÇAKMAK, HATİCE M. Et Al. "Sorafenib as a maintenance therapy in an adolescent with relapsed-metastatic osteosarcoma." Eskisehir Medical Journal, Eskisehir City Hospital , vol.3, 2022

ÇAKMAK, H. M. Et Al. (2022) . "Sorafenib as a maintenance therapy in an adolescent with relapsed-metastatic osteosarcoma." Eskisehir Medical Journal, Eskisehir City Hospital , vol.3.

@article{article, author={HATİCE MİNE ÇAKMAK Et Al. }, title={Sorafenib as a maintenance therapy in an adolescent with relapsed-metastatic osteosarcoma}, journal={Eskisehir Medical Journal, Eskisehir City Hospital}, year=2022}